Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Duality of interest The authors declare that there is no duality of interest associated with this manuscript
Tirzepatide mechanism of action Tirzepatide is a dual GLP-1 receptor and GIP receptor agonist, which is injected once weekly (subcutaneously)
Long- but not short-term adult-onset, isolated GH deficiency in male mice leads to deterioration of beta-cell function, which cannot be accounted for by changes in beta-cell mass
Scian, M
PMC NIH
Our dedicated healthcare professionals are ready to provide personalized guidance to determine if tirzepatide is the right therapeutic choice for your unique medical journey
US$ 23.81
US$ 25.66
US$ 21.66
US$ 24.99
US$ 27.90
US$ 27.78
US$ 25.44
US$ 25.13
